Products & Services

Oncology & PCR Equipment

CareConnect Worldwide Solutions is excited to announce the addition of Amoy Diagnostics as our newest partner to grow the oncology landscape in Ghana and West Africa. The strategic collaboration aims to enhance our distribution network by strengthening our existing partnerships with Amoy Dx.

Amoy Diagnostics (AmoyDx) is a leading provider of molecular diagnostics (MDx) solutions, specializing in precision oncology and personalized medicine. The company’s products focus on detecting genetic mutations, guiding targeted therapies, and improving cancer patient outcomes.

Product Ranges

AmoyDx offers a wide range of PCR-based and NGS-based assays for clinical and research applications, including:

1. PCR-Based Assays (Real-time PCR & qPCR)

•Companion Diagnostics (CDx): FDA- and CE-approved assays for targeted cancer therapies.

•EGFR Mutation Detection Kits: Essential for non-small cell lung cancer (NSCLC) treatment decisions.

•BRAF, KRAS, NRAS, PIK3CA Mutations: Used for colorectal, melanoma, and other cancers.

•ALK, ROS1, RET Fusion Detection Kits: Identifies gene fusions for personalized lung cancer treatment.

•Multi-Gene Panels: Covers multiple actionable mutations in a single test.

2. NGS-Based Assays (Next-Generation Sequencing)

•Comprehensive Genomic Profiling (CGP): Detects multiple mutations in a single run.

•Targeted NGS Panels: Focuses on specific gene alterations relevant to targeted therapy.

•Liquid Biopsy Solutions: Enables non-invasive cancer mutation detection from blood samples.

Scope & Applications

•Oncology Diagnostics: Supports clinicians in selecting the most effective targeted therapies.

•Companion Diagnostics (CDx): Works with pharmaceutical companies to provide regulatory-approved tests.

•Personalized Medicine: Helps tailor treatment plans based on genetic profiles.

•Clinical Research: Supports drug development and biomarker discovery.

AmoyDx’s innovative molecular diagnostics empower precision medicine worldwide, enhancing cancer diagnosis, treatment, and monitoring.

In-vitro Diagnostics

CareConnect Worldwide Solutions integrates In Vitro Diagnostics (IVD) with digital health technologies to enhance disease detection, patient monitoring, and healthcare accessibility. By leveraging rapid diagnostics, AI-driven analytics, and connected health platforms, CareConnect enables real-time decision-making for healthcare providers and empowers patients with remote and point-of-care testing solutions.

Rx Series

World leading test menu comprising over 100 dedicated high performance assays with excellent CVs. Consolidation of routine and novel tests on a single platform reduces costs and time. Unrivalled performance with excellent correlation to gold standard methods. Maximum uptime via robust hardware, minimal maintenance and unparalleled support Renowned for precision, reliability and accuracy, the RX series will reduce costly re-runs.

Low-cost equipment such as the
•Rx Monaco: Fully automated, cost effective solution for low to mid volume testing of 170 samples per hour.

• Rx Daytona: Fully automated, random access analyser capable of performing 450 tests per hour with STAT capabilities.

•Rx Imola: Fully automated, cost effective system delivering rapid and comprehensive testing of 560 samples per hour.

IQC & EQA

Acusera and QC Data management & Randox International Quality Assessment Scheme

RIQAS (Randox International Quality Assessment Scheme) and Randox Acusera are leading quality control solutions from Randox Laboratories, designed to ensure accuracy and reliability in laboratory diagnostics.
• RIQAS is the world’s largest External Quality Assessment (EQA) program, providing laboratories with independent performance evaluation across multiple analytes, enhancing accuracy and regulatory compliance.
• Randox Acusera offers third-party quality control (QC) materials, covering clinical chemistry, immunoassay, hematology, and molecular diagnostics, ensuring consistency in test results and reducing the need for frequent calibration.